The breakout cleared weeks ago. The mark is still there. You have stayed out of the sun. And yet the dark patch sits there, stubborn and unmoved, as if the breakout never actually left.
Here is the truth nobody explains when they hand you a brightening serum: fading a dark mark on brown skin is not a one-ingredient problem. It never was. And understanding why is the most useful thing you can know before you spend another cent on a product that promises to fix it in 28 days.
Why PIH is more complex on pigment rich skin- The Biology
Post-inflammatory hyperpigmentation (PIH) happens when inflammation in the skin — from a breakout, a scratch, or even an irritating product — triggers melanocytes to produce more pigment than usual. That excess pigment deposits in the skin layers, creating the dark mark you see.

Image: Thin skin epidermis stained with the Fontana silver method showing a large presence of melanin pigment in the basal and spinous layers. The pigmented cells are both melanocytes and keratinocytes.
On pigment rich skin (Fitzpatrick types III–V, which covers most South and Southeast Asian skin), this process is amplified. Melanocytes in melanin-rich skin are denser, more reactive, and faster to respond to inflammatory signals. Research from Southeast Asian dermatology clinics confirms that the same inflammatory event that produces a mark lasting 1–4 weeks in lighter skin can persist for 6 months to 5 years on brown skin.
This is not a flaw. It is biology. But it means that what works for one skin type often fails for another — and single-ingredient approaches that work on lighter skin simply do not have enough range to address what is happening in yours.
The real reason one ingredient is not enough

Most brightening products target one step in the pigmentation process. But PIH is not a single-step problem. It involves at least four distinct biological events — each requiring a different kind of intervention, at a different stage of the process.
Stage 1: The inflammatory trigger
Before pigment is even produced, the skin is responding to inflammation. Inflammatory cytokines — specifically TNF-alpha, IL-1beta, and IL-6 — activate the melanocyte and signal it to begin producing melanin. A product that only targets finished pigment never touches this stage. The trigger keeps firing. New marks keep forming.
Stage 2: Melanin synthesis
Once the melanocyte is activated, an enzyme called tyrosinase converts an amino acid (tyrosine) into melanin. This is the stage most brightening ingredients target — tyrosinase inhibitors. And they do help. But if the inflammatory signal from Stage 1 is still active, the tyrosinase keeps being replenished. You are suppressing production without switching off the factory.
Stage 3: Melanosome transfer
Melanin is packaged into structures called melanosomes, which are then transferred from melanocytes to surrounding skin cells (keratinocytes). Even if you reduce how much melanin is produced, if melanosome transfer is not addressed, the pigment still disperses through the skin layer and darkens the area. This is a separate mechanism — and requires a separate ingredient class.

Stage 4: UV reinforcement
Existing PIH marks contain melanocytes that are already sensitised. Every unprotected UV exposure activates them again, darkening the existing mark and potentially creating new ones. In a high-UV environment like tropical places, this happens every single day. No topical active — however well-formulated — can compensate for unprotected sun exposure. This is not optional sun protection advice. It is the scientific reason most dark mark treatments underperform: the UV exposure is continuously undoing the work.
What a complete approach actually requires
Closing the loop means addressing all four stages — not just the one your serum targets.
Stage 1: Calming, anti-inflammatory actives that quiet the cytokine signal before it reaches the melanocyte — bisabolol works here, suppressing NF-κB signalling at the source.
Stage 2: Tyrosinase inhibitors (licorice root, green tea EGCG, stable vitamin C) slow new pigment production. In tropical humidity, stability matters as much as concentration. Gentle keratolytics like willow bark help clear pigment-holding cells without disrupting the barrier or restarting Stage 1.
Stage 3: Niacinamide blocks melanosome transfer — a separate mechanism entirely, and one most products skip.
Stage 4: Broad-spectrum SPF 30+, daily, no exceptions. Supporting actives like ectoin help shield already-sensitised cells from pollution and blue light — but they support SPF, never replace it.
The honest timeline: 3–6 months for visible fading on melanin-rich skin with all four stages addressed. Anything promising results in a week is solving one stage, at most.
The biology isn't working against you. It's just specific about what it needs.
Curious which stage your skin is stuck at? Take our 5-minute skin assessment — Ziva Skin Quiz
Blogs you might like
What PIH Actually Is — And Why Brown Skin Carries It Longer Than Anyone Tells You
Microbiome: The Invisible Ecosystem Your Skincare Is Probably Disrupting
Why Your Oily Skin Is Actually Dehydrated - And Why That Changes Everything
Other Links for Further Reading
-
Post-inflammatory hyperpigmentation in Fitzpatrick III–V skin — PMC12041799 (2023)
-
Tranexamic acid + niacinamide vs. hydroquinone for PIH — Scientific Reports (2025)
-
Ceramide use during acne treatment — Draelos et al., Journal of Drugs in Dermatology (2023)
-
SPF as a preventive measure for PIH — PMC12062726, Australasian Journal of Dermatology (2025)
-
Centella asiatica and zero-irritation barrier support — International Journal of Molecular Sciences (2025)

